Objectives To audit the quality and safe management of sterile medical devices (SMDs), to examine the pharmacist's role in a multidisciplinary team, and to provide an example of hospital staff assessment of SMDs.
Methods SMD management was assessed using the National Agency for Support to the Performance of Health and Medical-Social Establishment tool in the Hospital Centre of Cannes, France, in August 2013. Safety policy in the healthcare establishment, and the SMD cycle in the hospital pharmacy, SMD cycle and care practices in the visceral–vascular–urological surgery care unit were evaluated by four health professionals and three hospital pharmacists. A total of 1850 references to SMDs for the hospital pharmacy and 1110 references to SMDs for the care unit were analysed. The percentage of risk control was defined as: 0–33% ‘low’, 34–66% ‘medium’, 67–100% ‘high’.
Results Risk control was ‘high’ (67%) for the safety policy in the health establishment, ‘high’ (68%) and ‘medium’ (64%) for the SMD cycle in the hospital pharmacy and the care unit, respectively, and ‘high’ (88%) for the care practices. Good scores were obtained in both services.
Conclusions Safety and quality standards were investigated, and satisfied. Training of health professionals and information about, and the presence of, detailed procedures for safety policy and care practices showed good results. The main weak points were a deficit in IT support and a lack of procedures in the SMD cycle. The hospital pharmacist was shown to be a key figure in the multidisciplinary team.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.